These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24940965)

  • 21. Obsessive-compulsive disorder comorbid with schizophrenia and bipolar disorder.
    Sharma LP; Reddy YCJ
    Indian J Psychiatry; 2019 Jan; 61(Suppl 1):S140-S148. PubMed ID: 30745688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence.
    Denys D; Zohar J; Westenberg HG
    J Clin Psychiatry; 2004; 65 Suppl 14():11-7. PubMed ID: 15554783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of treatments for patients with obsessive-compulsive disorder: a systematic review.
    Choi YJ
    J Am Acad Nurse Pract; 2009 Apr; 21(4):207-13. PubMed ID: 19366379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lamotrigine augmentation of serotonin reuptake inhibitors in severe and long-term treatment-resistant obsessive-compulsive disorder.
    Arrojo-Romero M; Tajes Alonso M; de Leon J
    Case Rep Psychiatry; 2013; 2013():612459. PubMed ID: 23936714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium Signaling Pathway Is Associated with the Long-Term Clinical Response to Selective Serotonin Reuptake Inhibitors (SSRI) and SSRI with Antipsychotics in Patients with Obsessive-Compulsive Disorder.
    Umehara H; Numata S; Tajima A; Nishi A; Nakataki M; Imoto I; Sumitani S; Ohmori T
    PLoS One; 2016; 11(6):e0157232. PubMed ID: 27281126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The medical treatment of obsessive-compulsive disorder and anxiety.
    Bandelow B
    CNS Spectr; 2008 Sep; 13(9 Suppl 14):37-46. PubMed ID: 18849910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ziprasidone Augmentation in an Adolescent with Obsessive Compulsive Disorder: A Case Report.
    Demirkaya SK; Alyanak B
    Psychopharmacol Bull; 2016 Mar; 46(1):73-76. PubMed ID: 27738375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of antipsychotics in obsessive compulsive disorder.
    Conti D; Girone N; Boscacci M; Casati L; Cassina N; Cerolini L; Giacovelli L; Viganò C; Conde MM; Cremaschi L; Dell'Osso BM
    Hum Psychopharmacol; 2024 May; 39(3):e2893. PubMed ID: 38340275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anxiety and depression: individual entities or two sides of the same coin?
    Nutt D
    Int J Psychiatry Clin Pract; 2004; 8 Suppl 1():19-24. PubMed ID: 24930685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ondansetron augmentation of serotonin reuptake inhibitors as a treatment strategy in obsessive-compulsive disorder.
    Andrade C
    J Clin Psychiatry; 2015 Jan; 76(1):e72-5. PubMed ID: 25650682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder in children and adolescents.
    Williams JS; Moore T; Collins CL; Thomas KA
    J Pediatr Pharmacol Ther; 2003 Jul; 8(3):177-86. PubMed ID: 23118677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current trends in drug treatment of obsessive-compulsive disorder.
    Decloedt EH; Stein DJ
    Neuropsychiatr Dis Treat; 2010 May; 6():233-42. PubMed ID: 20520787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trazodone Augmentation in OCD: A Case Series Report.
    Marazziti D; Gemignani A; Dell'osso L
    CNS Spectr; 1999 Dec; 4(12):48-9. PubMed ID: 18311107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An emerging role for escitalopram in the treatment of obsessive-compulsive disorder.
    Hedges DW; Woon FL
    Neuropsychiatr Dis Treat; 2007 Aug; 3(4):455-61. PubMed ID: 19300574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two cases of mild serotonin toxicity via 5-hydroxytryptamine 1A receptor stimulation.
    Nakayama H; Umeda S; Nibuya M; Terao T; Nisijima K; Nomura S
    Neuropsychiatr Dis Treat; 2014; 10():283-7. PubMed ID: 24627634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aripiprazole augmentation in patients with resistant obsessive compulsive disorder: a pilot study.
    Delle Chiaie R; Scarciglia P; Pasquini M; Caredda M; Biondi M
    Clin Pract Epidemiol Ment Health; 2011; 7():107-11. PubMed ID: 21686322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Preliminary Examination of Acceptance and Commitment Therapy Versus Exposure and Response Prevention for Patients with Obsessive-Compulsive Disorder on an Optimal Dose of SSRIs: A Randomized Controlled Trial in Iran.
    Zemestani M; Salavati M; Seyedolshohadayi A; Petersen JM; Ong CW; Twohig MP; Ghaderi E
    Behav Modif; 2022 May; 46(3):553-580. PubMed ID: 33356487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multidimensional Approaches for A Case of Severe Adult Obsessive - Compulsive Disorder.
    Shi Z; Mei X; Zhu Y; Shuai Y; Chen Y; Wu Y; Shen Y
    Shanghai Arch Psychiatry; 2017 Oct; 29(5):304-309. PubMed ID: 29276354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obsessive-compulsive symptoms in schizophrenia: a review.
    Grover S; Sahoo S; Surendran I
    Acta Neuropsychiatr; 2019 Apr; 31(2):63-73. PubMed ID: 30558683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Moving beyond first-line treatment options for OCD.
    Paxos C
    Ment Health Clin; 2022 Oct; 12(5):300-308. PubMed ID: 36405507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.